Business Model Breakdown
How Imax Corp Makes Money
IMAX
Market Cap
$1.7B
Annual Revenue
$378M
Profit Margin
10.5%
The Short Version
IMAX designs, manufactures, and licenses its proprietary high-resolution cameras, projection systems, and theater sound technologies to commercial cinema operators and institutional venues worldwide. The company generates revenue primarily through its unique joint revenue-sharing model, where it earns a percentage of box office receipts from films shown in IMAX-equipped theaters. Additional revenue streams include direct sales and leases of its projection systems, as well as maintenance services and post-production work to optimize films for the IMAX format. Essentially, IMAX enables a premium, immersive viewing experience that moviegoers are willing to pay more for, and it shares in that success with its partners.
Where the Revenue Comes From
Joint revenue sharing (percentage of box office sales from IMAX films)
System sales and leases (equipment and installation)
Maintenance and other services (ongoing support for systems)
Who buys: Global commercial cinema exhibitors (e.g., large multiplex chains), institutional theaters (e.g., museums, science centers), and film studios (for film production and remastering).
Why It Works (Competitive Advantages)
- ✔Proprietary, patented projection and sound technology, offering an unparalleled cinematic experience.
- ✔Strong global brand recognition and premium association with major blockbuster films and directors.
- ✔Extensive global network of licensed theaters (1,864 systems across 91 countries), leveraging an asset-light model.
- ✔Deep relationships with major film studios and directors, leading to exclusive 'Filmed For IMAX' content.
Economic Moat: Narrow (Brand Power, Intangible Assets/IP, Efficient Scale)
What Our Analysis Says
DVR Score as of April 7, 2026
IMAX has demonstrated robust financial performance, with Q4 2025 revenue up 35.1% YoY, global box office up 40% to a record $1.28 billion, and free cash flow soaring 187%. This strong momentum is driven by network expansion, successful local language content, and a promising 2026 film slate, directly addressing previous concerns about the core business's hypergrowth potential. The asset-light licensing model and strong brand provide a durable competitive advantage. While the 63.76x trailing P/E is high, the improving margins and cash flow trajectory support a premium. The temporary medical leave of CEO Richard Gelfond introduces short-term leadership risk, but the underlying business appears resilient and well-positioned for continued strong growth, though achieving a full 10x within 3-5 years from its current scale remains ambitious.